A well-orchestrated team to serve you best
Barthélemy Helg is active in Biotechnology, Real Estate and Finance. He is a founder of AB2 Bio Ltd (inflammatory diseases), Tiefenhof AG (residential real estate), and ACL Ltd (Middle East investments), and is also a board member with a number of privately-held companies and hedge funds.
He was, until the end of 2006, managing partner of Lombard Odier Darier Hentsch & Cie, the oldest and leading Geneva-based private bank. He was LODH Global Head of Investment Banking. He also supervised, as chairman of the board of Lombard Odier Darier Hentsch & Cie NV, LODH’s credit and emerging markets fixed income centre of competence. He was a member of the bank’s Credit, Risk, Finance and IT Committee. Previously, he was vice president at Nestlé SA, responsible for Mergers and Acquisitions and Investor Relations, where he oversaw more than 70 transactions on all continents. Prior to Nestlé, Bart worked for Goldman Sachs Financial Institutions Group in New York. Previously, he was a lawyer in Zurich, Geneva and Boston with Goodwin Procter.
Bart holds an LL.B/LL.M. from the University of Geneva (1987), an LL.M. from NYU (1993) and an MBA from Harvard Business School (1996). He is also a member of the bar in Geneva and in New York.
Bart is a Swiss citizen and speaks French, German and English.Back to people »